Similar articles for PMID: 21863215

Year	Number of Results
1979	1
1987	1
1988	1
1990	1
1992	1
1994	1
1996	2
2000	1
2002	1
2003	2
2004	2
2005	2
2006	5
2007	8
2008	12
2009	2
2010	6
2011	6
2012	10
2013	8
2014	15
2015	14
2016	10
2017	9
2018	3
2019	8
2020	11
2021	1

1

Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.

Patsenker E, Stoll M, Millonig G, Agaimy A, Wissniowski T, Schneider V, Mueller S, Brenneisen R, Seitz HK, Ocker M, Stickel F. Patsenker E, et al. Mol Med. 2011;17(11-12):1285-94. doi: 10.2119/molmed.2011.00149. Epub 2011 Aug 19. Mol Med. 2011. PMID: 21863215 Free PMC article.

2

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S, Fischer HP, Heller J, Zimmer A, Sauerbruch T. Trebicka J, et al. Liver Int. 2011 Jul;31(6):860-70. doi: 10.1111/j.1478-3231.2011.02496.x. Epub 2011 Mar 8. Liver Int. 2011. PMID: 21645218

3

Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.

Dai E, Zhang J, Zhang D, Yang L, Wang Y, Jiang X, Ye L, Li X, Liu H, Ma J, Jiang H. Dai E, et al. Hepatogastroenterology. 2014 Oct;61(135):2052-61. Hepatogastroenterology. 2014. PMID: 25713910

4

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.

Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Nat Med. 2006 Jun;12(6):671-6. doi: 10.1038/nm1421. Epub 2006 May 21. Nat Med. 2006. PMID: 16715087

5

Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.

Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Seth D, et al. World J Gastroenterol. 2014 Sep 28;20(36):13088-104. doi: 10.3748/wjg.v20.i36.13088. World J Gastroenterol. 2014. PMID: 25278703 Free PMC article.

6

Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.

Giannone FA, Baldassarre M, Domenicali M, Zaccherini G, Trevisani F, Bernardi M, Caraceni P. Giannone FA, et al. Lab Invest. 2012 Mar;92(3):384-95. doi: 10.1038/labinvest.2011.191. Epub 2011 Dec 19. Lab Invest. 2012. PMID: 22184091

7

Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.

Mahmoud MF, Swefy SE, Hasan RA, Ibrahim A. Mahmoud MF, et al. Eur J Pharmacol. 2014 Nov 5;742:118-24. doi: 10.1016/j.ejphar.2014.08.021. Epub 2014 Aug 30. Eur J Pharmacol. 2014. PMID: 25179573

8

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Jeong WI, Osei-Hyiaman D, Park O, Liu J, Bátkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G. Jeong WI, et al. Cell Metab. 2008 Mar;7(3):227-35. doi: 10.1016/j.cmet.2007.12.007. Cell Metab. 2008. PMID: 18316028 Free article.

9

Anandamide induces cell death through lipid rafts in hepatic stellate cells.

Yang Q, Liu HY, Zhang YW, Wu WJ, Tang WX. Yang Q, et al. J Gastroenterol Hepatol. 2010 May;25(5):991-1001. doi: 10.1111/j.1440-1746.2009.06122.x. Epub 2010 Jan 4. J Gastroenterol Hepatol. 2010. PMID: 20059638

10

Suppression of CB1 cannabinoid receptor by lentivirus mediated small interfering RNA ameliorates hepatic fibrosis in rats.

Chen SW, Wu BY, Xu SP, Fan KX, Yan L, Gong Y, Wen JB, Wu DH. Chen SW, et al. PLoS One. 2012;7(12):e50850. doi: 10.1371/journal.pone.0050850. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed